✦ LIBER ✦

Smoking and cancer: Research in etiology and prevention at the national cancer institute

✍ Scribed by Gio B. Gori

Publisher: John Wiley and Sons
Year: 1972
Tongue: English
Weight: 366 KB
Volume: 30
Category: Article
ISSN: 0008-543X
DOI: 10.1002/1097-0142(197211)30:5<1340::aid-cncr2820300529>3.0.co;2-t

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Cancer centers and the National Cancer I

Cancer centers and the National Cancer Institute

✍ Carl G. Baker 📂 Article 📅 1972 🏛 John Wiley and Sons 🌐 English ⚖ 152 KB 👁 2 views

American Cancer Society-National Cancer

American Cancer Society-National Cancer Institute. National conference on cancer research and clinical investigation (replacing the eighth national cancer conference)

📂 Article 📅 1976 🏛 John Wiley and Sons 🌐 English ⚖ 66 KB 👁 1 views

Legislative history of the National Canc

Legislative history of the National Cancer Institute and the National Cancer Program

✍ Dorothy A. Tisevich 📂 Article 📅 1996 🏛 John Wiley and Sons 🌐 English ⚖ 132 KB 👁 2 views

Primary prevention, smoking, and smoking

Primary prevention, smoking, and smoking cessation : Implications for future trends in lung cancer prevention

✍ David M. Burns 📂 Article 📅 2000 🏛 John Wiley and Sons 🌐 English ⚖ 150 KB 👁 2 views

Cancer research prior to the National Ca

Cancer research prior to the National Cancer Act and activities before and after the signing

✍ Carl G. Baker 📂 Article 📅 1996 🏛 John Wiley and Sons 🌐 English ⚖ 164 KB 👁 1 views

The prostate, lung, colorectal, and ovar

The prostate, lung, colorectal, and ovarian cancer screening trial of the national cancer institute

✍ John K. Gohagan; Philip C. Prorok; Barnett S. Kramer; Richard B. Hayes; Joyce E. 📂 Article 📅 1995 🏛 John Wiley and Sons 🌐 English ⚖ 481 KB 👁 2 views

The two-year pilot phase of the Prostate, Lung, Colorectal, and Ovarian (PLCO) trial concluded September 29, 1994. The goals, organization, operation, and recruitment status of the trial are discussed. The PLCO trial is a 16year randomized controlled screening trial involving 148,000 male and female